EGF816 (Nazartinib)
Catalog No. A14416
EGF816 (Nazartinib)是新型的突变选择性EGFR共价抑制剂。克服了NSCLC中T790M介导的耐药性。
Catalog Num | A14416 |
---|---|
M. Wt | 495.02 |
Formula | C26H31ClN6O2 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1508250-71-2 |
Synonyms | EGF-816, EGF 816, Nazartinib |
SMILES | CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2C4CCCCN(C4)C(=O)C=CCN(C)C)C(=CC=C3)Cl |
EGF816 (Nazartinib)是新型的突变选择性EGFR共价抑制剂。克服了NSCLC中T790M介导的耐药性。
In vitro | DMSO | 92 mg/mL (185.85 mM) | |
Water | Insoluble | ||
Ethanol | 92 mg/mL (185.85 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.2 mL | 101.01 mL | 202.01 mL |
0.5 mM | 4.04 mL | 20.2 mL | 40.4 mL |
1 mM | 2.02 mL | 10.1 mL | 20.2 mL |
5 mM | 0.4 mL | 2.02 mL | 4.04 mL |
*The above data is based on the productmolecular weight 495.02. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.